Intra-Cellular Therapies Inc. (ITCI)
Delisted
2 Apr 2025
NASDAQ (NGS) NASDAQ (NGS) Primary $
131. 87
0
0%
$
7.05B Market Cap
- P/E Ratio
- Div Yield
0 Volume
-1.61 Eps
$ 131.87
Previous Close Investors:
Day Range
131.87 131.87
Year Range
64.09 131.98
Want to track ITCI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Intra-Cellular Therapies Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MC Mike Clark Cassady Schiller Wealth Management LLC | 13 | $1.09 | $1.04 | -$0.05 | -4.59% |
